Abeona Therapeutics Statistics

Total Valuation

ABEO has a market cap or net worth of $284.58 million. The enterprise value is $185.03 million.

Market Cap	284.58M
Enterprise Value	185.03M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

ABEO has 43.31 million shares outstanding. The number of shares has increased by 115.29% in one year.

Shares Outstanding	43.31M
Shares Change (YoY)	+115.29%
Shares Change (QoQ)	+87.54%
Owned by Insiders (%)	5.14%
Owned by Institutions (%)	48.62%
Float	28.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	398.57
PB Ratio	3.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.48, with a Debt / Equity ratio of 0.32.

Current Ratio	7.48
Quick Ratio	7.38
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.35

Financial Efficiency

Return on equity (ROE) is -127.38% and return on invested capital (ROIC) is -63.48%.

Return on Equity (ROE)	-127.38%
Return on Assets (ROA)	-37.81%
Return on Capital (ROIC)	-63.48%
Revenue Per Employee	n/a
Profits Per Employee	-$626,179
Employee Count	84
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +77.09% in the last 52 weeks. The beta is 1.51, so ABEO's price volatility has been higher than the market average.

Beta (5Y)	1.51
52-Week Price Change	+77.09%
50-Day Moving Average	5.98
200-Day Moving Average	5.64
Relative Strength Index (RSI)	57.45
Average Volume (20 Days)	223,457

Short Selling Information

The latest short interest is 2.77 million, so 6.39% of the outstanding shares have been sold short.

Short Interest	2.77M
Short Previous Month	2.67M
Short % of Shares Out	6.39%
Short % of Float	9.89%
Short Ratio (days to cover)	9.89

Income Statement

Revenue	n/a
Gross Profit	-31.29M
Operating Income	-56.74M
Pretax Income	-76.66M
Net Income	-52.60M
EBITDA	-54.75M
EBIT	-56.74M
Earnings Per Share (EPS)	-$1.78

Full Income Statement

Balance Sheet

The company has $122.71 million in cash and $23.17 million in debt, giving a net cash position of $99.54 million or $2.30 per share.

Cash & Cash Equivalents	122.71M
Total Debt	23.17M
Net Cash	99.54M
Net Cash Per Share	$2.30
Equity (Book Value)	73.24M
Book Value Per Share	1.76
Working Capital	109.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.20 million and capital expenditures -$1.52 million, giving a free cash flow of -$43.72 million.

Operating Cash Flow	-42.20M
Capital Expenditures	-1.52M
Free Cash Flow	-43.72M
FCF Per Share	-$1.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,155.34%

Dividends & Yields

ABEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-115.29%
Shareholder Yield	-115.29%
Earnings Yield	-18.48%
FCF Yield	-15.36%

Dividend Details

Analyst Forecast

The average price target for ABEO is $18.00, which is 173.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	173.97%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	144.16%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 5, 2022. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Jul 5, 2022
Split Type	Reverse
Split Ratio	0.04:1

Scores

ABEO has an Altman Z-Score of -7.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.19
Piotroski F-Score	2